These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19220164)

  • 21. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.
    Du D; Targett D; Stolberg E; Canali A
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):69-75. PubMed ID: 23681835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM; Meltzer EO
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
    Gastpar H; Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azelastine nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1997 May; 39(1000):45-7. PubMed ID: 9150688
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
    Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis.
    Lee C; Corren J
    Expert Opin Pharmacother; 2007 Apr; 8(5):701-9. PubMed ID: 17376024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
    Golden SJ; Craig TJ
    J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S7-12. PubMed ID: 10478514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
    Arcimowicz M; Samoliński B; Zawisza E
    Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
    Lieberman P; Meltzer EO; LaForce CF; Darter AL; Tort MJ
    Allergy Asthma Proc; 2011; 32(2):151-8. PubMed ID: 21352639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
    Berger WE; Shah S; Lieberman P; Hadley J; Price D; Munzel U; Bhatia S
    J Allergy Clin Immunol Pract; 2014; 2(2):179-85. PubMed ID: 24607046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC; Amar NJ; Wheeler W; Sacks H
    Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.